KIDS OrthoPediatrics Corp.
$30.80▲ +29.30%
Healthcare
Other
After hours
$30.80▲ +0.00%
Oct 28, 4:00 PM ET
Volume 1.79M
Avg Volume (10D) 291.9K
Key Metrics & Fundamentals
Market Cap
$804.18M
P/E Ratio
–
Div Yield
0.00%
52W Range
14.42 - 31.51
% vs 50 MA
3.46%
% vs 200 MA
22.90%
RSI-14
57.7
MACD Histogram
+0.2200
Beta (1Y vs SPY)
0.65
Free Cash Flow
-$3.12M
Gross Rev
$70.51M
Gross Profit
$52.37M
EBITDA
$1.31M
COGS
$18.14M
Operating Exp
$56.43M
Operating Income
-$4.07M
EBIT
-$4.07M
Pretax Income
-$6.93M
Net Income
-$7.16M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News
OrthoPediatrics: Q3 Earnings Snapshot
Associated Press · Oct 28, 2026 2:34 PM ET
Top Midday Gainers
MT Newswires · Oct 28, 2026 1:36 PM ET
Truist Adjusts Price Target on OrthoPediatrics to $28 From $22, Maintains Hold Rating
MT Newswires · Oct 28, 2026 5:13 AM ET
OrthoPediatrics Corp (KIDS) (Q3 2026) Earnings Call Highlights: Record Revenue and Raised Guidance
GuruFocus.com · Oct 28, 2026 3:04 AM ET
OrthoPediatrics: 3 Key Takeaways for Long-Term Investors
Motley Fool · Oct 27, 2026 9:57 PM ET
OrthoPediatrics Q3 Earnings Call Highlights
MarketBeat · Oct 27, 2026 8:04 PM ET
OrthoPediatrics (KIDS) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 27, 2026 7:28 PM ET
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
Zacks · Oct 27, 2026 5:20 PM ET
OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance
GlobeNewswire · Oct 27, 2026 4:05 PM ET
OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations
GlobeNewswire · Oct 27, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See KIDS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.